Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Hallikainen, Merja
Gertz, Hermann-Josef
Froelich, Lutz
Felician, Olivier
Eriksdotter, Maria
Didic, Mira
de Mendonca, Alexandre
Dartigues, Jean-Francois
Ceccaldi, Mathieu
Yener, Goersev
Bernabei, Roberto
Wallin, Asa K.
Bocchetta, Martina
Aguera, Eduardo
Sarazin, Marie
Tsolaki, Magda
Mehrabian, Shima
Traykov, Latchezar
Pasquier, Florence
Peters, Oliver
Salmon, Eric
Visser, Pieter Jelle
Sanchez-Castellano, Carmen
Frisoni, Giovanni B.
Santana, Isabel
Mecocci, Patrizia
Martinez-Lage, Pablo
Lleo, Alberto
Lawlor, Brian
Kurz, Alexander
Wolf, Henrike
Jessen, Frank
Heuser, Isabell
Hausner, Lucrezia
Hasselbalch, Steen G.
Rikkert, Marcel Olde
Zekry, Dina
Monsch, Andreas
Galluzzi, Samantha
Nobili, Flavio
Orgogozo, Jean-Marc
Kehoe, Patrick Gavin
Nordberg, Agneta
Jones, Roy W.
Bullock, Roger
Wilkinson, David
Wilcock, Gordon

February 2015

We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Conso...

Les biomarqueurs du liquide cérébro-spinal dans la maladie d’Alzheimer : un outil de recherche utile dans la pratique clinique courante des consultations mémoire pour les cas complexes

Magnin, Eloi
Dumurgier, J.
Bouaziz-Amar, E.
Bombois, S.
Wallon, D.
Gabelle, A.
Lehmann, S.
Blanc, F.
Bousiges, O.
Hannequin, D.
Jung, B.
Miguet-Alfonsi, C.
Quillard, M.
Pasquier, F.
Peoc’h, K.
Laplanche, J.
Hugon, J.
Paquet, C.

April 2017

International audienceThe role of biomarkers in clinical research was recently highlighted in the ne...

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease

Keerthanaa Balasubramanian Shanthi
Sreeram Krishnan
P Rani

August 2015

Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diag...

The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia.

Olde Rikkert, M.G.M.
Lauque, S.
Frolich, L.
Vellas, B.
Dekkers, W.J.M.

January 2005

Contains fulltext : 48524.pdf (publisher's version ) (Closed access)Across Europe ...

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.

Frankfort, S.V.
Tulner, L.R.
Campen, J.P. van
Verbeek, M.M.
Jansen, R.W.M.M.
Beijnen, J.H.

January 2008

Item does not contain fulltextThis review addresses recent developments in amyloid beta (Abeta), tot...

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia

Anna H. Noel-Storr
Leon Flicker
Craig W. Ritchie
Giang Huong Nguyen
Tarun Gupta
Phillip Wood
Josephine Walton
Meera Desai
Danielle Fraser Solomon
Emma Molena
Rosemary Worrall
Anja Hayen
Prateek Choudhary
Emma Ladds
Krista L. Lanctot
Frans R. Verhey
Jenny M. Mccleery
Gillian E. Mead
Linda Clare
Mario Fioravanti
Chris Hyde
Sue Marcus
Rupert Mcshane

January 2013

Background: Although recent diagnostic criteria for Alzheimer's disease propose the use of biomarker...

Clinical consensus guidelines on the application of cerebrospinal fluid biomarkers for Alzheimer\u27s disease diagnosis: recommendations of the Irish Network for Biomarkers in Neurodegeneration

Miller, A.-M.
Begley, E.
Coen, R.
Doyle, M.
Dunne, J.
Hutchinson, S.
Kennelly, S. P.
Kenny, R. A.
Killeen, R.
Lynch, A.
O\u27Dwyer, S.
O\u27Neill, Cora
O\u27Sullivan, S.
Rowan, M.
Sheehy, N.
McGuigan, C.
Lawlor, Brian A.

November 2016

It is accepted that a lumbar puncture (LP) and cerebrospinal fluid (CSF) biomarker analysis support ...

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Mattsson, N.
Andreasson, U.
Persson, S.
Arai, H.
Batish, S.D.
Bernardini, S.
Bocchio-Chiavetto, L.
Blankenstein, M.A.
Carrillo, M.C.
Chalbot, S.
Coart, E.
Chiasserini, D.
Cutler, N.
Dahlfors, G.
Duller, S.
Fagan, A.M.
Forlenza, O.
Frisoni, G.B.
Galasko, D.
Galimberti, D.
Hampel, H.
Handberg, A.
Heneka, M.T.
Herskovits, A.Z.
Herukka, S.K.
Holtzman, D.M.
Humpel, C.
Hyman, B.T.
Iqbal, K.
Jucker, M.
Kaeser, S.A.
Kaiser, E.
Kapaki, E.
Kidd, D.
Klivenyi, P.
Knudsen, C.S.
Kummer, M.P.
Lui, J.
Llado, A.
Lewczuk, P.
Li, Q.X.
Martins, R.
Masters, C.
McAuliffe, J.
Mercken, M.
Moghekar, A.
Molinuevo, J.L.
Montine, T.J.
Nowatzke, W.
O'Brien, R.
Otto, M.
Paraskevas, G.P.
Parnetti, L.
Petersen, R.C.
Prvulovic, D.
Reus, H.P.M. de
Rissman, R.A.
Scarpini, E.
Stefani, A.
Soininen, H.
Schroder, J.
Shaw, L.M.
Skinningsrud, A.
Skrogstad, B.
Spreer, A.
Talib, L.
Teunissen, C.
Trojanowski, J.Q.
Tumani, H.
Umek, R.M.
Broeck, B. Van
Vanderstichele, H.
Vecsei, L.
Verbeek, M.M.
Windisch, M.
Zhang, J.
Zetterberg, H.
Blennow, K.

January 2011

Contains fulltext : 98400.pdf (publisher's version ) (Closed access)BACKGROUND: Th...

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.

Verwey, N.A.
Flier, W.M. van der
Blennow, K.
Clark, C.
Sokolow, S.
Deyn, P.P. de
Galasko, D.
Hampel, H.
Hartmann, T.
Kapaki, E.
Lannfelt, L.
Mehta, P.D.
Parnetti, L.
Petzold, A.
Pirttilä, T.
Saleh, L.
Skinningsrud, A.
Swieten, J.C. van
Verbeek, M.M.
Wiltfang, J.
Younkin, S.
Scheltens, P.
Blankenstein, M.A.

January 2009

Item does not contain fulltextBACKGROUND: Different cerebrospinal fluid (CSF) amyloid-beta 1-42 (Abe...

The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie

Sancesario, GM
Toniolo, S
Chiasserini, D
Di Santo, SG
Zegeer, J
Bernardi, G
Musicco, M
Caltagirone, C
Parnetti, L
Bernardini, S

January 2017

Although the use of cerebrospinal fluid (CSF) amyloid β1-42 (Aβ42), tau (T-tau), and phosphorylated ...

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Simonsen, Anja Hviid
Herukka, Sanna-Kaisa
Andreasen, Niels
Baldeiras, Ines
Bjerke, Maria
Blennow, Kaj
Engelborghs, Sebastiaan
Frisoni, Giovanni B.
Gabryelewicz, Tomasz
Galluzzi, Samantha
Handels, Ron
Kramberger, Milica G.
Kulczynska, Agnieszka
Luis Molinuevo, Jose
Mroczko, Barbara
Nordberg, Agneta
Oliveira, Catarina Resende
Otto, Markus
Rinne, Juha O.
Rot, Uros
Saka, Esen
Soininen, Hilkka
Struyfs, Hanne
Suardi, Silvia
Visser, Pieter Jelle
Winblad, Bengt
Zetterberg, Henrik
Waldemar, Gunhild

March 2017

This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Hallikainen, Merja
Gertz, Hermann-Josef
Froelich, Lutz
Felician, Olivier
Eriksdotter, Maria
Didic, Mira
de Mendonca, Alexandre
Dartigues, Jean-Francois
Ceccaldi, Mathieu
Yener, Goersev
Bernabei, Roberto
Wallin, Asa K.
Bocchetta, Martina
Aguera, Eduardo
Sarazin, Marie
Tsolaki, Magda
Mehrabian, Shima
Traykov, Latchezar
Pasquier, Florence
Peters, Oliver
Salmon, Eric
Visser, Pieter Jelle
Sanchez-Castellano, Carmen
Frisoni, Giovanni B.
Santana, Isabel
Mecocci, Patrizia
Martinez-Lage, Pablo
Lleo, Alberto
Lawlor, Brian
Kurz, Alexander
Wolf, Henrike
Jessen, Frank
Heuser, Isabell
Hausner, Lucrezia
Hasselbalch, Steen G.
Rikkert, Marcel Olde
Zekry, Dina
Monsch, Andreas
Galluzzi, Samantha
Nobili, Flavio
Orgogozo, Jean-Marc
Kehoe, Patrick Gavin
Nordberg, Agneta
Jones, Roy W.
Bullock, Roger
Wilkinson, David
Wilcock, Gordon

February 2015

We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Conso...

Les biomarqueurs du liquide cérébro-spinal dans la maladie d’Alzheimer : un outil de recherche utile dans la pratique clinique courante des consultations mémoire pour les cas complexes

Magnin, Eloi
Dumurgier, J.
Bouaziz-Amar, E.
Bombois, S.
Wallon, D.
Gabelle, A.
Lehmann, S.
Blanc, F.
Bousiges, O.
Hannequin, D.
Jung, B.
Miguet-Alfonsi, C.
Quillard, M.
Pasquier, F.
Peoc’h, K.
Laplanche, J.
Hugon, J.
Paquet, C.

April 2017

International audienceThe role of biomarkers in clinical research was recently highlighted in the ne...

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease

Keerthanaa Balasubramanian Shanthi
Sreeram Krishnan
P Rani

August 2015

Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diag...

The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia.

Olde Rikkert, M.G.M.
Lauque, S.
Frolich, L.
Vellas, B.
Dekkers, W.J.M.

January 2005

Contains fulltext : 48524.pdf (publisher's version ) (Closed access)Across Europe ...

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature.

Frankfort, S.V.
Tulner, L.R.
Campen, J.P. van
Verbeek, M.M.
Jansen, R.W.M.M.
Beijnen, J.H.

January 2008

Item does not contain fulltextThis review addresses recent developments in amyloid beta (Abeta), tot...

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia

Anna H. Noel-Storr
Leon Flicker
Craig W. Ritchie
Giang Huong Nguyen
Tarun Gupta
Phillip Wood
Josephine Walton
Meera Desai
Danielle Fraser Solomon
Emma Molena
Rosemary Worrall
Anja Hayen
Prateek Choudhary
Emma Ladds
Krista L. Lanctot
Frans R. Verhey
Jenny M. Mccleery
Gillian E. Mead
Linda Clare
Mario Fioravanti
Chris Hyde
Sue Marcus
Rupert Mcshane

January 2013

Background: Although recent diagnostic criteria for Alzheimer's disease propose the use of biomarker...

Clinical consensus guidelines on the application of cerebrospinal fluid biomarkers for Alzheimer\u27s disease diagnosis: recommendations of the Irish Network for Biomarkers in Neurodegeneration

Miller, A.-M.
Begley, E.
Coen, R.
Doyle, M.
Dunne, J.
Hutchinson, S.
Kennelly, S. P.
Kenny, R. A.
Killeen, R.
Lynch, A.
O\u27Dwyer, S.
O\u27Neill, Cora
O\u27Sullivan, S.
Rowan, M.
Sheehy, N.
McGuigan, C.
Lawlor, Brian A.

November 2016

It is accepted that a lumbar puncture (LP) and cerebrospinal fluid (CSF) biomarker analysis support ...

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

Mattsson, N.
Andreasson, U.
Persson, S.
Arai, H.
Batish, S.D.
Bernardini, S.
Bocchio-Chiavetto, L.
Blankenstein, M.A.
Carrillo, M.C.
Chalbot, S.
Coart, E.
Chiasserini, D.
Cutler, N.
Dahlfors, G.
Duller, S.
Fagan, A.M.
Forlenza, O.
Frisoni, G.B.
Galasko, D.
Galimberti, D.
Hampel, H.
Handberg, A.
Heneka, M.T.
Herskovits, A.Z.
Herukka, S.K.
Holtzman, D.M.
Humpel, C.
Hyman, B.T.
Iqbal, K.
Jucker, M.
Kaeser, S.A.
Kaiser, E.
Kapaki, E.
Kidd, D.
Klivenyi, P.
Knudsen, C.S.
Kummer, M.P.
Lui, J.
Llado, A.
Lewczuk, P.
Li, Q.X.
Martins, R.
Masters, C.
McAuliffe, J.
Mercken, M.
Moghekar, A.
Molinuevo, J.L.
Montine, T.J.
Nowatzke, W.
O'Brien, R.
Otto, M.
Paraskevas, G.P.
Parnetti, L.
Petersen, R.C.
Prvulovic, D.
Reus, H.P.M. de
Rissman, R.A.
Scarpini, E.
Stefani, A.
Soininen, H.
Schroder, J.
Shaw, L.M.
Skinningsrud, A.
Skrogstad, B.
Spreer, A.
Talib, L.
Teunissen, C.
Trojanowski, J.Q.
Tumani, H.
Umek, R.M.
Broeck, B. Van
Vanderstichele, H.
Vecsei, L.
Verbeek, M.M.
Windisch, M.
Zhang, J.
Zetterberg, H.
Blennow, K.

January 2011

Contains fulltext : 98400.pdf (publisher's version ) (Closed access)BACKGROUND: Th...

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease.

Verwey, N.A.
Flier, W.M. van der
Blennow, K.
Clark, C.
Sokolow, S.
Deyn, P.P. de
Galasko, D.
Hampel, H.
Hartmann, T.
Kapaki, E.
Lannfelt, L.
Mehta, P.D.
Parnetti, L.
Petzold, A.
Pirttilä, T.
Saleh, L.
Skinningsrud, A.
Swieten, J.C. van
Verbeek, M.M.
Wiltfang, J.
Younkin, S.
Scheltens, P.
Blankenstein, M.A.

January 2009

Item does not contain fulltextBACKGROUND: Different cerebrospinal fluid (CSF) amyloid-beta 1-42 (Abe...

The Clinical Use of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease Diagnosis: The Italian Selfie

Sancesario, GM
Toniolo, S
Chiasserini, D
Di Santo, SG
Zegeer, J
Bernardi, G
Musicco, M
Caltagirone, C
Parnetti, L
Bernardini, S

January 2017

Although the use of cerebrospinal fluid (CSF) amyloid β1-42 (Aβ42), tau (T-tau), and phosphorylated ...

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia

Simonsen, Anja Hviid
Herukka, Sanna-Kaisa
Andreasen, Niels
Baldeiras, Ines
Bjerke, Maria
Blennow, Kaj
Engelborghs, Sebastiaan
Frisoni, Giovanni B.
Gabryelewicz, Tomasz
Galluzzi, Samantha
Handels, Ron
Kramberger, Milica G.
Kulczynska, Agnieszka
Luis Molinuevo, Jose
Mroczko, Barbara
Nordberg, Agneta
Oliveira, Catarina Resende
Otto, Markus
Rinne, Juha O.
Rot, Uros
Saka, Esen
Soininen, Hilkka
Struyfs, Hanne
Suardi, Silvia
Visser, Pieter Jelle
Winblad, Bengt
Zetterberg, Henrik
Waldemar, Gunhild

March 2017

This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...

The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey

Hallikainen, Merja
Gertz, Hermann-Josef
Froelich, Lutz
Felician, Olivier
Eriksdotter, Maria
Didic, Mira
de Mendonca, Alexandre
Dartigues, Jean-Francois
Ceccaldi, Mathieu
Yener, Goersev
Bernabei, Roberto
Wallin, Asa K.
Bocchetta, Martina
Aguera, Eduardo
Sarazin, Marie
Tsolaki, Magda
Mehrabian, Shima
Traykov, Latchezar
Pasquier, Florence
Peters, Oliver
Salmon, Eric
Visser, Pieter Jelle
Sanchez-Castellano, Carmen
Frisoni, Giovanni B.
Santana, Isabel
Mecocci, Patrizia
Martinez-Lage, Pablo
Lleo, Alberto
Lawlor, Brian
Kurz, Alexander
Wolf, Henrike
Jessen, Frank
Heuser, Isabell
Hausner, Lucrezia
Hasselbalch, Steen G.
Rikkert, Marcel Olde
Zekry, Dina
Monsch, Andreas
Galluzzi, Samantha
Nobili, Flavio
Orgogozo, Jean-Marc
Kehoe, Patrick Gavin
Nordberg, Agneta
Jones, Roy W.
Bullock, Roger
Wilkinson, David
Wilcock, Gordon

February 2015

We investigated the use of Alzheimer's disease (AD) biomarkers in European Alzheimer's Disease Conso...

Les biomarqueurs du liquide cérébro-spinal dans la maladie d’Alzheimer : un outil de recherche utile dans la pratique clinique courante des consultations mémoire pour les cas complexes

Magnin, Eloi
Dumurgier, J.
Bouaziz-Amar, E.
Bombois, S.
Wallon, D.
Gabelle, A.
Lehmann, S.
Blanc, F.
Bousiges, O.
Hannequin, D.
Jung, B.
Miguet-Alfonsi, C.
Quillard, M.
Pasquier, F.
Peoc’h, K.
Laplanche, J.
Hugon, J.
Paquet, C.

April 2017

International audienceThe role of biomarkers in clinical research was recently highlighted in the ne...

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer’s disease

Keerthanaa Balasubramanian Shanthi
Sreeram Krishnan
P Rani

August 2015

Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers for diag...

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent

Abstract

Extracted data

Amyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent

Abstract

Extracted data

Related items

Related items